New: our quarterly report on the S&P 500, read from 500 companies’ own filings and calls.
Read the Q3 2026 report
Acumen Pharmaceuticals, Inc. (ABOS) vs Seres Therapeutics, Inc. (MCRB)
- Acumen Pharmaceuticals, Inc. ABOS 0.19 0.00%
- Seres Therapeutics, Inc. MCRB 1.24 −6.77%
Acumen Pharmaceuticals, Inc. and Seres Therapeutics, Inc. are both Biotechnology companies. Acumen Pharmaceuticals, Inc. and Seres Therapeutics, Inc. are of similar size ($14.0M and $13.6M). Acumen Pharmaceuticals, Inc. has the higher net margin (−510.1% vs −2,209.6%) and the higher return on invested capital (0.00% vs −1,267.8%). Across the 14 metrics below, Seres Therapeutics, Inc. leads on 8 and Acumen Pharmaceuticals, Inc. on 6.
Valuation
Profitability
| Metric | ABOS | MCRB | Biotechnology median |
|---|---|---|---|
| Gross margin | 100.00% | 100.00% | 70.18% |
| Operating margin | (550.97%) | (3,656.89%) | 0.00% |
| Net margin | (510.10%) | (2,209.55%) | 0.00% |
| Free cash flow margin | (518.80%) | — | 0.00% |
| Return on equity | (162.72%) | (144.35%) | (51.58%) |
| Return on assets | (91.28%) | (44.85%) | (45.91%) |
| Return on invested capital | 0.00% | (1,267.77%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack